Alume Biosciences

La Jolla, CA · Founded 2017 · Privately Held (backing)

Developer of a nerve illumination technology designed to help doctors perform precision surgery. Alume Biosciences is based in La Jolla, CA and was founded in 2017. Its last reported valuation was $128 million in Jan 2023. It has raised $31.2 million across 6 recorded rounds; the latest was a $2.2 million seed round in Mar 2026.

Last reported valuation
$127.8M
Oct 2026
Priced at
—
Total raised
$31.2M
Last round
Seed Round
Mar 2026
What is Alume Biosciences worth?
$127.8Mlast reported valuation · Oct 2026

Alume Biosciences's last reported valuation, Jan 2023. Nothing priced has surfaced since.

Free account
More of Alume Biosciences with a free account
  • ·Watch Alume Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Alume Biosciences funding history

6 rounds
DateRoundRaisedPost-money
Mar 2026Seed Round$2.2M▮
Oct 2025Early Stage VC$6.9M▮
Dec 2022Early Stage VC$12.8M▮
Apr 2022Seed Round$4.0M▮
Aug 2020Seed Round$4.0M▮
Jun 2019Early Stage VC$5.8M▮
Unlock post-money valuations

Membership and data by Private Market View

Alume Biosciences valuation

Alume Biosciences's last reported valuation was $128 million in Jan 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Alume Biosciences raised?

Alume Biosciences has raised $31.2 million across 6 recorded rounds since 2019. The largest was a $6.9 million early-stage round in Oct 2025; the most recent was a $2.2 million seed round in Mar 2026.

Alume Biosciences has filed 7 Form Ds with the SEC since 2019, most recently in May 2026 ($2.2 million sold to 4 investors).

How Alume Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Alume Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Alume Biosciences

What is Alume Biosciences worth?
Alume Biosciences is valued at $127.8M as of Oct 2026. Alume Biosciences's last reported valuation, Jan 2023. Nothing priced has surfaced since.
How much has Alume Biosciences raised?
Alume Biosciences has raised $31.2M in total funding across 6 recorded rounds.
When did Alume Biosciences last raise?
Alume Biosciences last raised in Mar 2026 (Seed Round), raising $2.2M.